 Lorna Browne
Concepts (322)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 29 | 2023 | 3046 | 3.450 |
Why?
| | Tomography, X-Ray Computed | 16 | 2024 | 2285 | 3.110 |
Why?
| | Vascular Stiffness | 11 | 2022 | 407 | 1.940 |
Why?
| | Heart Defects, Congenital | 7 | 2023 | 671 | 1.920 |
Why?
| | Magnetic Resonance Angiography | 8 | 2022 | 220 | 1.900 |
Why?
| | Magnetic Resonance Imaging, Cine | 11 | 2023 | 172 | 1.700 |
Why?
| | Hypertension, Pulmonary | 9 | 2024 | 1728 | 1.480 |
Why?
| | Aortic Coarctation | 3 | 2023 | 70 | 1.430 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 4 | 2022 | 76 | 1.430 |
Why?
| | Hemodynamics | 15 | 2022 | 1012 | 1.300 |
Why?
| | Computed Tomography Angiography | 5 | 2023 | 97 | 1.200 |
Why?
| | Aorta | 11 | 2021 | 386 | 1.150 |
Why?
| | Pulmonary Artery | 11 | 2024 | 1015 | 1.150 |
Why?
| | Coronary Vessels | 5 | 2022 | 227 | 1.130 |
Why?
| | Infant | 26 | 2024 | 7961 | 1.050 |
Why?
| | Child | 47 | 2024 | 18412 | 1.040 |
Why?
| | Infant, Newborn | 18 | 2023 | 5045 | 0.940 |
Why?
| | Heart | 5 | 2023 | 612 | 0.910 |
Why?
| | Retrospective Studies | 30 | 2024 | 12546 | 0.900 |
Why?
| | Stenosis, Pulmonary Vein | 1 | 2023 | 17 | 0.840 |
Why?
| | Imaging, Three-Dimensional | 8 | 2022 | 511 | 0.820 |
Why?
| | Tetralogy of Fallot | 5 | 2022 | 81 | 0.820 |
Why?
| | Coronary Circulation | 3 | 2022 | 133 | 0.810 |
Why?
| | Heart Ventricles | 8 | 2023 | 712 | 0.800 |
Why?
| | Pulmonary Veins | 1 | 2023 | 81 | 0.800 |
Why?
| | Blood Flow Velocity | 8 | 2022 | 387 | 0.800 |
Why?
| | Child, Preschool | 20 | 2024 | 9114 | 0.790 |
Why?
| | Adolescent | 35 | 2024 | 17841 | 0.740 |
Why?
| | Cardiac-Gated Imaging Techniques | 1 | 2020 | 16 | 0.710 |
Why?
| | Body Surface Area | 1 | 2020 | 27 | 0.710 |
Why?
| | Aorta, Thoracic | 5 | 2023 | 256 | 0.700 |
Why?
| | Anesthesia | 1 | 2022 | 117 | 0.700 |
Why?
| | Humans | 80 | 2024 | 114662 | 0.690 |
Why?
| | Ventricular Dysfunction, Left | 6 | 2020 | 358 | 0.690 |
Why?
| | Foreign Bodies | 1 | 2021 | 96 | 0.680 |
Why?
| | Pulmonary Valve | 2 | 2019 | 89 | 0.640 |
Why?
| | Ventricular Function, Left | 6 | 2023 | 467 | 0.630 |
Why?
| | Osteomyelitis | 2 | 2012 | 105 | 0.620 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2023 | 329 | 0.620 |
Why?
| | Diagnostic Imaging | 2 | 2020 | 275 | 0.620 |
Why?
| | Postoperative Complications | 5 | 2020 | 2128 | 0.600 |
Why?
| | Glycogen Storage Disease | 1 | 2018 | 20 | 0.600 |
Why?
| | Pulse Wave Analysis | 7 | 2022 | 207 | 0.590 |
Why?
| | Echocardiography | 6 | 2023 | 553 | 0.560 |
Why?
| | Heart Rate | 1 | 2020 | 709 | 0.550 |
Why?
| | Male | 44 | 2023 | 55583 | 0.540 |
Why?
| | Bronchiolitis | 1 | 2017 | 81 | 0.530 |
Why?
| | Scimitar Syndrome | 1 | 2016 | 6 | 0.530 |
Why?
| | Arteries | 1 | 2018 | 247 | 0.530 |
Why?
| | Lung Diseases, Interstitial | 2 | 2019 | 508 | 0.520 |
Why?
| | Female | 44 | 2024 | 59493 | 0.520 |
Why?
| | Staphylococcal Infections | 2 | 2012 | 340 | 0.520 |
Why?
| | Ultrasonography | 3 | 2015 | 634 | 0.520 |
Why?
| | Hemoptysis | 1 | 2016 | 34 | 0.510 |
Why?
| | Spermatocele | 1 | 2015 | 2 | 0.500 |
Why?
| | Ventricular Dysfunction, Right | 5 | 2022 | 217 | 0.490 |
Why?
| | Scrotum | 1 | 2015 | 23 | 0.480 |
Why?
| | Image Enhancement | 2 | 2022 | 159 | 0.480 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.480 |
Why?
| | Myocardium | 2 | 2017 | 913 | 0.480 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.480 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2017 | 174 | 0.470 |
Why?
| | Testis | 1 | 2015 | 133 | 0.470 |
Why?
| | Preoperative Care | 2 | 2017 | 319 | 0.440 |
Why?
| | Testicular Neoplasms | 1 | 2015 | 96 | 0.440 |
Why?
| | Fontan Procedure | 3 | 2020 | 157 | 0.440 |
Why?
| | Arterial Pressure | 3 | 2019 | 99 | 0.430 |
Why?
| | Community-Acquired Infections | 2 | 2012 | 141 | 0.420 |
Why?
| | Growth Plate | 1 | 2012 | 32 | 0.380 |
Why?
| | Severe Combined Immunodeficiency | 1 | 2011 | 19 | 0.380 |
Why?
| | Intestinal Obstruction | 1 | 2011 | 40 | 0.370 |
Why?
| | Young Adult | 13 | 2023 | 10466 | 0.360 |
Why?
| | Peritonitis | 1 | 2011 | 77 | 0.360 |
Why?
| | Cardiac Surgical Procedures | 3 | 2020 | 414 | 0.360 |
Why?
| | Lung Diseases | 2 | 2014 | 701 | 0.350 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2020 | 109 | 0.350 |
Why?
| | Predictive Value of Tests | 5 | 2022 | 1796 | 0.340 |
Why?
| | Radiology | 2 | 2022 | 141 | 0.340 |
Why?
| | Postoperative Care | 1 | 2011 | 222 | 0.340 |
Why?
| | Myocardial Stunning | 1 | 2009 | 5 | 0.340 |
Why?
| | Aortic Diseases | 3 | 2020 | 106 | 0.340 |
Why?
| | Coronary Angiography | 2 | 2022 | 304 | 0.340 |
Why?
| | Cardiology | 2 | 2022 | 259 | 0.330 |
Why?
| | Coronary Vessel Anomalies | 1 | 2009 | 30 | 0.330 |
Why?
| | Aortic Arch Syndromes | 1 | 2009 | 2 | 0.330 |
Why?
| | Contrast Media | 3 | 2022 | 345 | 0.320 |
Why?
| | Diagnosis, Differential | 5 | 2018 | 1342 | 0.320 |
Why?
| | Heart Diseases | 2 | 2022 | 331 | 0.320 |
Why?
| | Technetium Tc 99m Medronate | 1 | 2008 | 4 | 0.310 |
Why?
| | Ventricular Function, Right | 5 | 2022 | 250 | 0.310 |
Why?
| | Turner Syndrome | 2 | 2019 | 44 | 0.310 |
Why?
| | Puberty, Precocious | 1 | 2008 | 13 | 0.300 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 76 | 0.300 |
Why?
| | Abnormalities, Multiple | 1 | 2009 | 178 | 0.300 |
Why?
| | Hypothyroidism | 1 | 2008 | 64 | 0.290 |
Why?
| | Reproducibility of Results | 8 | 2023 | 2763 | 0.270 |
Why?
| | Ovary | 1 | 2008 | 191 | 0.270 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 191 | 0.260 |
Why?
| | Risk | 2 | 2018 | 812 | 0.250 |
Why?
| | Biopsy | 3 | 2018 | 1036 | 0.240 |
Why?
| | Infant, Premature | 2 | 2023 | 476 | 0.240 |
Why?
| | Pulmonary Valve Insufficiency | 2 | 2022 | 41 | 0.240 |
Why?
| | Respiration | 2 | 2022 | 180 | 0.230 |
Why?
| | Stress, Mechanical | 4 | 2019 | 445 | 0.230 |
Why?
| | Treatment Outcome | 11 | 2021 | 9088 | 0.220 |
Why?
| | Fetal Heart | 1 | 2023 | 37 | 0.220 |
Why?
| | Pregnancy Trimester, Third | 1 | 2023 | 79 | 0.220 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 92 | 0.220 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2024 | 190 | 0.210 |
Why?
| | Heart Valve Diseases | 2 | 2022 | 161 | 0.210 |
Why?
| | Pancreatitis, Chronic | 1 | 2023 | 40 | 0.210 |
Why?
| | Iothalamic Acid | 1 | 2022 | 4 | 0.210 |
Why?
| | Cardiac Catheterization | 4 | 2022 | 534 | 0.210 |
Why?
| | Pulmonary Atresia | 1 | 2022 | 20 | 0.200 |
Why?
| | Anesthesia, General | 1 | 2022 | 44 | 0.200 |
Why?
| | Perfusion Imaging | 2 | 2019 | 51 | 0.200 |
Why?
| | Regional Blood Flow | 2 | 2021 | 424 | 0.200 |
Why?
| | Hepatic Veins | 1 | 2021 | 29 | 0.190 |
Why?
| | Case-Control Studies | 5 | 2019 | 3003 | 0.190 |
Why?
| | Artifacts | 1 | 2022 | 114 | 0.190 |
Why?
| | Pediatrics | 1 | 2009 | 979 | 0.190 |
Why?
| | Electric Power Supplies | 1 | 2021 | 48 | 0.180 |
Why?
| | Portal Vein | 1 | 2021 | 76 | 0.180 |
Why?
| | Vascular Malformations | 1 | 2021 | 47 | 0.180 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 6 | 0.180 |
Why?
| | Hemangiosarcoma | 1 | 2021 | 18 | 0.180 |
Why?
| | Gestational Age | 1 | 2023 | 760 | 0.180 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2022 | 3252 | 0.180 |
Why?
| | Radiation Dosage | 1 | 2021 | 133 | 0.180 |
Why?
| | Cardiovascular Diseases | 3 | 2018 | 1727 | 0.180 |
Why?
| | Heart Neoplasms | 1 | 2021 | 49 | 0.180 |
Why?
| | Follow-Up Studies | 4 | 2021 | 4411 | 0.180 |
Why?
| | End Stage Liver Disease | 1 | 2021 | 63 | 0.170 |
Why?
| | Gastric Bypass | 1 | 2021 | 92 | 0.170 |
Why?
| | Sarcopenia | 1 | 2021 | 63 | 0.170 |
Why?
| | Kidney | 3 | 2022 | 1188 | 0.170 |
Why?
| | Pulmonary Circulation | 2 | 2019 | 407 | 0.170 |
Why?
| | Neoplasms, Second Primary | 1 | 2021 | 92 | 0.170 |
Why?
| | Heart Function Tests | 1 | 2019 | 58 | 0.170 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 188 | 0.170 |
Why?
| | Aortic Valve | 2 | 2020 | 398 | 0.170 |
Why?
| | Athetosis | 1 | 2019 | 7 | 0.160 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 14 | 0.160 |
Why?
| | Cardiovascular Abnormalities | 1 | 2019 | 10 | 0.160 |
Why?
| | Chorea | 1 | 2019 | 11 | 0.160 |
Why?
| | Congenital Hypothyroidism | 1 | 2019 | 11 | 0.160 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2021 | 223 | 0.160 |
Why?
| | Fetus | 2 | 2023 | 700 | 0.160 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2020 | 122 | 0.160 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 178 | 0.160 |
Why?
| | Eating | 1 | 2021 | 344 | 0.160 |
Why?
| | Marfan Syndrome | 1 | 2018 | 42 | 0.160 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 207 | 0.160 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2018 | 16 | 0.150 |
Why?
| | Obesity, Morbid | 1 | 2021 | 197 | 0.150 |
Why?
| | Cloaca | 1 | 2018 | 48 | 0.150 |
Why?
| | Urogenital Abnormalities | 1 | 2018 | 48 | 0.150 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 119 | 0.150 |
Why?
| | Shear Strength | 1 | 2018 | 65 | 0.150 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 101 | 0.150 |
Why?
| | Thermodilution | 1 | 2017 | 12 | 0.150 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2094 | 0.150 |
Why?
| | Stroke Volume | 4 | 2022 | 504 | 0.150 |
Why?
| | Liver Function Tests | 1 | 2018 | 103 | 0.150 |
Why?
| | Prognosis | 5 | 2021 | 3329 | 0.140 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2017 | 22 | 0.140 |
Why?
| | Perfusion | 1 | 2017 | 148 | 0.140 |
Why?
| | Blood Vessels | 1 | 2018 | 180 | 0.140 |
Why?
| | Cholangitis, Sclerosing | 1 | 2018 | 66 | 0.140 |
Why?
| | Vascular Remodeling | 1 | 2018 | 153 | 0.140 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2021 | 683 | 0.140 |
Why?
| | Thoracic Diseases | 1 | 2016 | 13 | 0.140 |
Why?
| | Prevalence | 1 | 2023 | 2251 | 0.140 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2016 | 35 | 0.130 |
Why?
| | Systole | 3 | 2022 | 171 | 0.130 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 227 | 0.130 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2022 | 473 | 0.130 |
Why?
| | Nitric Oxide | 1 | 2021 | 823 | 0.130 |
Why?
| | Mutation | 2 | 2024 | 3345 | 0.130 |
Why?
| | Sensitivity and Specificity | 2 | 2012 | 1692 | 0.130 |
Why?
| | Fibrosis | 1 | 2017 | 453 | 0.130 |
Why?
| | Metformin | 1 | 2018 | 276 | 0.120 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 272 | 0.120 |
Why?
| | Prospective Studies | 6 | 2023 | 6219 | 0.120 |
Why?
| | Exercise Test | 1 | 2017 | 544 | 0.120 |
Why?
| | Coronary Thrombosis | 1 | 2015 | 25 | 0.120 |
Why?
| | Risk Assessment | 4 | 2018 | 2968 | 0.120 |
Why?
| | Oxygen Consumption | 1 | 2017 | 588 | 0.120 |
Why?
| | Research Design | 1 | 2020 | 928 | 0.120 |
Why?
| | Calcinosis | 1 | 2017 | 242 | 0.120 |
Why?
| | Liver Transplantation | 1 | 2021 | 707 | 0.120 |
Why?
| | Disease Progression | 2 | 2018 | 2380 | 0.110 |
Why?
| | Toes | 1 | 2014 | 26 | 0.110 |
Why?
| | Arteriovenous Malformations | 1 | 2014 | 24 | 0.110 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1355 | 0.110 |
Why?
| | Edema | 1 | 2014 | 119 | 0.110 |
Why?
| | Comorbidity | 1 | 2017 | 1448 | 0.100 |
Why?
| | Ligation | 1 | 2012 | 75 | 0.100 |
Why?
| | Vocal Cord Paralysis | 1 | 2012 | 21 | 0.100 |
Why?
| | Surgical Instruments | 1 | 2012 | 47 | 0.100 |
Why?
| | Lung | 2 | 2023 | 3559 | 0.100 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2012 | 50 | 0.100 |
Why?
| | Biomechanical Phenomena | 3 | 2020 | 668 | 0.100 |
Why?
| | Gadolinium DTPA | 1 | 2012 | 47 | 0.100 |
Why?
| | Barium Sulfate | 1 | 2011 | 15 | 0.100 |
Why?
| | North America | 2 | 2022 | 256 | 0.090 |
Why?
| | Adult | 8 | 2023 | 30544 | 0.090 |
Why?
| | Radiography, Abdominal | 1 | 2011 | 32 | 0.090 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 1012 | 0.090 |
Why?
| | Age Factors | 4 | 2019 | 2894 | 0.090 |
Why?
| | Bronchi | 1 | 2012 | 231 | 0.090 |
Why?
| | Coronary Artery Disease | 1 | 2017 | 607 | 0.090 |
Why?
| | American Heart Association | 2 | 2022 | 264 | 0.090 |
Why?
| | Colonography, Computed Tomographic | 1 | 2010 | 3 | 0.090 |
Why?
| | Glomerulonephritis, IGA | 1 | 2009 | 7 | 0.090 |
Why?
| | Myocardial Perfusion Imaging | 2 | 2020 | 34 | 0.080 |
Why?
| | Ventricular Remodeling | 2 | 2022 | 226 | 0.080 |
Why?
| | Bacteremia | 1 | 2010 | 160 | 0.080 |
Why?
| | Myocardial Contraction | 2 | 2020 | 313 | 0.080 |
Why?
| | Adnexal Diseases | 1 | 2008 | 2 | 0.080 |
Why?
| | Ovarian Cysts | 1 | 2008 | 8 | 0.080 |
Why?
| | Age Determination by Skeleton | 1 | 2008 | 16 | 0.080 |
Why?
| | Myocardial Infarction | 1 | 2015 | 927 | 0.070 |
Why?
| | Pericardial Effusion | 1 | 2008 | 21 | 0.070 |
Why?
| | Dilatation, Pathologic | 2 | 2018 | 55 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4408 | 0.070 |
Why?
| | Thyroid Hormones | 1 | 2008 | 53 | 0.070 |
Why?
| | Pleural Effusion | 1 | 2008 | 47 | 0.070 |
Why?
| | Radiopharmaceuticals | 1 | 2008 | 157 | 0.070 |
Why?
| | Thyroid Gland | 1 | 2008 | 82 | 0.070 |
Why?
| | Pelvis | 1 | 2008 | 90 | 0.070 |
Why?
| | Middle Aged | 5 | 2019 | 26733 | 0.070 |
Why?
| | Syndrome | 1 | 2008 | 333 | 0.070 |
Why?
| | Radiography, Thoracic | 1 | 2008 | 150 | 0.070 |
Why?
| | Puberty | 1 | 2008 | 135 | 0.070 |
Why?
| | Hemorrhage | 1 | 2009 | 620 | 0.060 |
Why?
| | Risk Factors | 4 | 2021 | 8632 | 0.060 |
Why?
| | Time Factors | 3 | 2021 | 6114 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2009 | 637 | 0.050 |
Why?
| | Pregnancy | 3 | 2023 | 5518 | 0.050 |
Why?
| | Bromocriptine | 1 | 2022 | 26 | 0.050 |
Why?
| | Observer Variation | 1 | 2023 | 295 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2538 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 249 | 0.050 |
Why?
| | Reference Values | 1 | 2023 | 743 | 0.050 |
Why?
| | Ultrasonography, Prenatal | 1 | 2023 | 236 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 18 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2010 | 1481 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2022 | 440 | 0.050 |
Why?
| | Consensus | 1 | 2023 | 537 | 0.050 |
Why?
| | Creatinine | 1 | 2022 | 425 | 0.050 |
Why?
| | Indazoles | 1 | 2021 | 58 | 0.050 |
Why?
| | Acute Disease | 1 | 2023 | 911 | 0.040 |
Why?
| | Iron-Binding Proteins | 1 | 2000 | 38 | 0.040 |
Why?
| | Norwood Procedures | 1 | 2020 | 22 | 0.040 |
Why?
| | Recurrence | 1 | 2023 | 935 | 0.040 |
Why?
| | Bevacizumab | 1 | 2021 | 115 | 0.040 |
Why?
| | Biomarkers | 2 | 2022 | 3408 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 36 | 0.040 |
Why?
| | Cation Transport Proteins | 1 | 2000 | 123 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 48 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2022 | 604 | 0.040 |
Why?
| | Waiting Lists | 1 | 2021 | 211 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 175 | 0.040 |
Why?
| | Diastole | 1 | 2019 | 130 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 641 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 141 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 80 | 0.040 |
Why?
| | Autografts | 1 | 2019 | 40 | 0.040 |
Why?
| | Incidence | 2 | 2018 | 2313 | 0.040 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2018 | 65 | 0.040 |
Why?
| | Societies, Medical | 1 | 2022 | 663 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 136 | 0.040 |
Why?
| | Pilot Projects | 1 | 2022 | 1373 | 0.040 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2018 | 15 | 0.040 |
Why?
| | Biliary Tract | 1 | 2018 | 16 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1121 | 0.040 |
Why?
| | Pyrimidines | 1 | 2021 | 376 | 0.040 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2018 | 70 | 0.040 |
Why?
| | Vascular Resistance | 1 | 2019 | 337 | 0.040 |
Why?
| | Cardiovascular System | 1 | 2019 | 125 | 0.040 |
Why?
| | Sulfonamides | 1 | 2021 | 445 | 0.040 |
Why?
| | Cardiac Output | 1 | 2017 | 143 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2000 | 695 | 0.030 |
Why?
| | United States | 2 | 2022 | 12181 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1214 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 69 | 0.030 |
Why?
| | Oxygen | 1 | 2018 | 854 | 0.030 |
Why?
| | Blood Pressure | 1 | 2019 | 1538 | 0.030 |
Why?
| | Ultrasonography, Doppler | 1 | 2014 | 105 | 0.030 |
Why?
| | Triplets | 1 | 2012 | 2 | 0.030 |
Why?
| | Pregnancy, Multiple | 1 | 2012 | 14 | 0.030 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 225 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 2015 | 234 | 0.030 |
Why?
| | Angiography | 1 | 2012 | 174 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 1958 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 401 | 0.020 |
Why?
| | Cesarean Section | 1 | 2012 | 169 | 0.020 |
Why?
| | Ireland | 1 | 2010 | 24 | 0.020 |
Why?
| | Bronchoscopy | 1 | 2012 | 245 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2018 | 1072 | 0.020 |
Why?
| | Airway Obstruction | 1 | 2012 | 168 | 0.020 |
Why?
| | Reoperation | 1 | 2012 | 514 | 0.020 |
Why?
| | Endoscopy | 1 | 2012 | 246 | 0.020 |
Why?
| | Liver | 1 | 2018 | 1637 | 0.020 |
Why?
| | Methylprednisolone | 1 | 2009 | 81 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4622 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2015 | 1262 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 2508 | 0.020 |
Why?
| | Aged | 2 | 2019 | 19069 | 0.020 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 373 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2009 | 447 | 0.020 |
Why?
| | Renal Dialysis | 1 | 2009 | 374 | 0.020 |
Why?
| | COS Cells | 1 | 2000 | 175 | 0.010 |
Why?
| | Gene Dosage | 1 | 2000 | 129 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 343 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 6345 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2000 | 511 | 0.010 |
Why?
| | Transfection | 1 | 2000 | 866 | 0.010 |
Why?
| | Rats | 1 | 2000 | 4958 | 0.010 |
Why?
| | Mice | 1 | 2000 | 14863 | 0.000 |
Why?
| | Animals | 1 | 2000 | 31698 | 0.000 |
Why?
|
|
Browne's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|